Royalty Pharma plc (RPRX) reports Q1 results
Tweet
Share
E-mail
Get Alerts RPRX Hot Sheet
Price: $54.26 -1.97%
Financial Fact:
Total revenues and other income: 10K
Today's EPS Names:
DTGI, CRMT, MAYS, More
Financial Fact:
Total revenues and other income: 10K
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Royalty Pharma plc (NASDAQ: RPRX) reported Q1 results. Revenue for the quarter came in at $684 million versus the consensus estimate of $806.84 million.
For earnings history and earnings-related data on Royalty Pharma plc (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras CEO says investors misunderstood margin guidance
- Micron Technology (MU) Tops Q3 EPS by $4.62, Guidance Beats
- BMO Capital on FedEx (FDX): 'Guidance Appears Consistent With Our Forecasts'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
